Malkowicz S B
Department of Surgery, University of Pennsylvania Medical Center, Philadelphia, USA.
Urol Clin North Am. 1996 Nov;23(4):665-75. doi: 10.1016/s0094-0143(05)70344-x.
The management of postprostatectomy serum prostate-specific antigen elevation is hampered by the inability to determine the location of the recurrence accurately and the lack of data demonstrating a survival advantage from any of the available therapies. Treatment must be individualized for each patient.
前列腺切除术后血清前列腺特异性抗原升高的管理受到阻碍,原因在于无法准确确定复发部位,且缺乏数据表明任何现有疗法能带来生存优势。治疗必须针对每位患者进行个体化。